Oncogene-addicted NSCLC highlights from WCLC24 and ESMO24 – Lung Connect

Joshua Bauml: The U.S. FDA approved our targeted therapy in combination with for NSCLC with specific EGFR mutations

Patrick Hwu: Offering support as a sounding board while still allowing our mentees to practice self-reflection

Sébastien Couraud: Alexis Cortot about air pollutants interactions with lung cancers molecular alerations

Addressing long term challenges of the 500,000 childhood cancer survivors in Europe – SIOP Europe

Yüksel Ürün: Adjuvant nivolumab vs placebo in localized RCC patients at high recurrence risk post-nephrectomy by Robert J. Motzer

Yara Abdou: Navigating Treatment pathways in Metastatic HR+ Breast cancer

Jasmin Hundal: Ricki Fairley defining Black Breast Cancer as “constellation of exposures, experiences, and lack of science

Naveen Pemmaraju: Nice to see so many colleagues form around the world at MPNCoandD Congress

Ending Cancer drug shortages in rural areas – American Society of Clinical Oncology